Skip to content

MDMA: all studies

Page 284 of 345: studies 2,831 to 2,840 of 3,446, newest first. Back to the MDMA overview

Research

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.

Addictive Behaviors Reports December 1, 2023 Grant Jones, Felipe Herrmann, Erica Wang 6 citations

Hallucinogen dependence and abuse are DSM-IV diagnoses that are associated with significant morbidity, yet the specific hallucinogens that are most strongly linked to dependence and abuse are understudied. We used recent data from the National Survey on Drug Use and Health (2015-2020) and multivariable logistic regression to test the relationships that lifetime use of seven individual...

DOI: 10.1016/j.abrep.2023.100513 (opens in new tab) Full text (opens in new tab) Hallucinogens Substance abuse Addiction research Drug dependence +1

Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.

Drug Discovery Today December 1, 2023 Taeho Greg Rhee, Pasha A. Davoudian, Gerard Sanacora et al. 20 citations

Psychiatric disorders represent the largest cause of disability worldwide. Global interests in psychedelic substances as potentially therapeutic agents for psychiatric disorders has recently re-emerged. Here, we review progress in the development of psychedelic compounds that have potential therapeutic effects as well as the safety concerns. We include psilocybin, N,N-dimethyltryptamine (DMT),...

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic Medicine December 1, 2023 William Brennan, Alex R. Kelman, Alexander Belser 43 citations

Psychedelic-assisted therapy has gained significant attention in recent years. However, there is a lack of empirical clarity on the role of psychosocial interventions (PIs) in clinical trials of psychedelic treatment due in part to deficiencies in reporting practices found in the existing literature. These PI include non-drug support or interventions provided by psychotherapists or facilitators...

DOI: 10.1089/psymed.2023.0007 (opens in new tab) Full text (opens in new tab) Clinical trials Psychedelic-assisted therapy pat Psychosocial interventions Reporting practices +7

Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials

Journal of Psychedelic Studies November 20, 2023 Tahlia R. Harrison 23 citations

Abstract Background and aims Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how...

DOI: 10.1556/2054.2023.00267 (opens in new tab) Full text (opens in new tab) Anxiety Clinical trial Informed consent Inclusion mineral +5

“New” drugs associated with chemsex? 2C-B in sexual context. A case report and review

European Psychiatry November 17, 2023 J. Curto Ramos, H. Dolengevich, M.a. Morillas Romerosa et al.

Introduction The intentional use of drugs before or during sexual intercourse (chemsex), due to its impact on mental health, is a phenomenon of high importance in men who have sex with men. Objectives We report the case of a patient with polysubstance acute intoxication, including 2C-B, in order to review the evidence about the mechanisms of action of 2C-B, its efects on sexual pleasure,...

Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness

Journal of Psychedelic Studies November 16, 2023 Danelle Jones 48 citations

Recent years have seen a global explosion in the field of psychedelic research, popularizing of use of non-ordinary states of consciousness to aid in PTSD, anxiety and depression, end of life and a growing sense that the use of substances like MDMA, psilocybin and others may become mainstream approaches to treating persistent challenges in these marginalized populations.As we destigmatize these...

Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis

Journal of Psychoactive Drugs November 15, 2023 Anees Bahji, Isis Lunsky, Gilmar Gutierrez et al. 21 citations

There has been a resurgence in psychedelic research for managing psychiatric conditions in recent years. This study aimed to present a comprehensive review of the current state of the field by applying a systematic search strategy for articles on the effectiveness and tolerability of four psychedelic-assisted therapies (psilocybin, lysergic acid diethylamide [LSD],...

DOI: 10.1080/02791072.2023.2278586 (opens in new tab) Full text (opens in new tab) PTSD Psychedelic-assisted therapies Anxiety disorders Mental health treatment +3

Treatment‐resistant depression

Australian Dental Journal November 13, 2023 Ivan Darby 8 citations

Treatment-resistant depressionGiven the current focus on mental health especially among dental practitioners, one of the issues we may see is an increase in treatment-resistant depression (TRD).In the management of depression, the ultimate therapeutic goal is remission, but Souery et al (J Clin Psych 2006, 67 (suppl 6): 16-22) suggested that only 60%-70% of patients respond to the first line...

DOI: 10.1111/adj.13001 (opens in new tab) Conceptualization Periodontology Library science Citation +2

Has there been an increase in nitrous oxide use and associated harms in Australia? An analysis of triangulated data sources, 2003-2020.

The International journal on drug policy November 2023 Rachel Sutherland, Nicola Man, Jared A Brown et al.

There is growing concern, globally, regarding use of nitrous oxide (N2O) for intoxication purposes. This paper aims to examine trends in: (i) past six month N2O use among a sample of people who use regularly use ecstasy and/or other illicit stimulants (2003-2020); (ii) volume of N2O-related Google searches and social media posts (2009-2020); and (iii) N2O-related calls to Poisons Information...

Addiction specialists' attitudes toward psychedelics: A National Survey.

American Journal on Addictions November 1, 2023 Amanda Kim, Joji Suzuki 15 citations

In recent years, there has been accelerating scientific and public interest in the use of psychedelics to treat mental health disorders. Our study's objective was to assess the attitudes of addiction specialists regarding therapeutic psychedelics. Our study utilized an anonymous online survey to assess the opinions of 145 addiction specialists regarding the therapeutic promise, potential risks,...